27.02.2023 • News

Avantium and Origin Partner on PEF

Avantium is partnering with Origin Materials to accelerate the mass production of furandicarboxylic acid (FDCA) and plant-based, fully recyclable plastic, polyethylene furanoate (PEF).

The partnership will combine Avantium’s proprietary YXY process with Origin’s patented technology platform that turns carbon found in sustainable wood residues into building-block chemicals such as chloromethylfurfural (CMF), which can be used to make FDCA.

The company has already started to build a commercial-scale FDCA plant in Delfzijl, the Netherlands, while Origin reached mechanical completion this month on its first commercial manufacturing plant for CMF and derivatives in Sarnia, Canada, with start-up expected in the second quarter of 2023.   

Under their collaboration, Avantium has granted Origin a non-exclusive license to use certain parts of its YXY process – including certain patent rights – for enabling the conversion of CMF derivatives into FDCA at a 100,000 t/y plant. Avantium added that it will also develop a “bridge” between the companies’ respective technologies.

© Shutterstock/Africa Studio
© Shutterstock/Africa Studio

Origin paid Avantium €5 million upfront last year and will also pay a milestone fee of €7.5 million, as well as subsequent license fees upon achieving certain development milestones.

"The technologies of both companies are highly complementary and will also enable the use of non-edible, renewable feedstocks for the production of FDCA and PEF, meeting the expectations of brand owners and consumers worldwide,” said Avantium CEO Tom van Aken.

The partners have also entered into a conditional offtake agreement whereby Avantium will sell FDCA and PEF to Origin Materials from its FDCA pilot plant in Geleen, the Netherlands, in 2023 and from the Delfzjil plant once it goes into commercial operation in 2024.

Author: Elaine Burridge, Freelance Journalist

Interview

Leading Transformation
The Path to Sustainable Growth

Leading Transformation

As Executive Vice President of International Chemicals since early 2024, Antje Gerber has been steering Sasol through a pivotal reset—focused on resilience, innovation, and bold sustainability goals.

Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read